BioSpace News Archive

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announces advancement in its proprietary MEAI- based binge behavior regulator program through the granting of patent approval in Hong Kong by the Hong Kong Patent Office

Thermo Fisher Scientific Inc., the world leader in serving science, is contributing to the sustainability of biologics therapy manufacturing by leveraging plant-based materials, rather than fossil fuel materials, to deliver lower-carbon, biobased films for its single-use technology bioprocessing containers (BPCs).

Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for the diagnostic, nutrition and cell culture markets.

Mytonomy Inc., a leader in cloud solutions for health education and engagement, announced that the company is a proud participant of the American Academy of Orthopaedic Surgeons’ Patient-Reported Outcome Measures Vendor Program.